contributes to the diagnosis of APS
contributes to the diagnosis of APS
Because Beta-2 Microglobulin is increased with blood cell cancers, it may be useful as a tumor marker. Though it can be used to assess kidney function as well.
Protein electrophoresis fraction; elevated reflects immune or inflammatory activity.
Dietary Peptide Related Markers
Dietary Peptide Related Markers
A non-essential amino acid.
Dietary Peptide Related Markers
Dietary Peptide Related Markers
Dietary Peptide Related Markers
Beta-alanine is a non-essential amino acid involved in various metabolic processes in the body. It's not typically required from the diet because the body can produce it. In medical testing, the levels of beta-alanine in urine are measured to assess its concentration in the body. Under normal conditions, beta-alanine is efficiently converted into other substances, including alpha-ketoglutarate, through a process that depends on vitamin B-6. When beta-alanine appears at elevated levels in urine, it can indicate disruptions in its usual metabolic pathways or suggest the presence of certain health conditions. High levels might be caused by dietary factors, the presence of unusual bacteria, or specific medical conditions like Chronic Fatigue Syndrome, which can be associated with gastrointestinal and genitourinary (relating to the genital and urinary organs) infections. Therefore, monitoring the levels of beta-alanine can help in diagnosing health issues, determining their severity, and guiding dietary recommendations to manage these levels effectively, such as a diet low in protein and certain nitrogen compounds.
A non-essential amino acid
B-Vitamin Markers
Amino acid end product of the pyrimidine metabolism.
Amino acid end product of the pyrimidine metabolism.
B-Vitamin Markers
Amino acid end product of the pyrimidine metabolism.
The Beta-amyloid 42/40 ratio (Aβ42/40) compares two amyloid-beta peptides in blood or CSF to detect Alzheimer’s-type biology: because Aβ42 more readily forms plaques, its level in fluids falls relative to Aβ40, so a lower ratio increases the likelihood of amyloid plaque pathology. It’s more reliable than Aβ42 alone and is often paired with phospho-tau markers (p-tau217 or p-tau181) to improve rule-in/rule-out accuracy and guide next steps like amyloid PET or CSF confirmation. Interpretation is assay-specific—always use the cutoff printed on your report—and should consider symptoms, cognitive testing, and other medical factors; gray-zone results may warrant repeat testing. The ratio does not diagnose Alzheimer’s by itself, but it can triage patients earlier and less invasively in a memory workup.